Neurop, Inc
NeurOp, Inc. is a clinical-stage biotechnology company developing new medicines for central nervous system disorders, including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression. Its technology targets the GluN2B subunit of neuronal NMDA receptors and its potential therapeutic benefit. Multi-year funding from the NIH supports NeurOp's research and development programs for NP10679, its drug candidate for the prevention of ischemic damage during a stroke or subarachnoid hemorrhage (SAH) and severe pain. For more information, please visit
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Neurop, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Neurop, Inc
2 distinct titles indexed · top 2 shown.
- 1board member
- 1psicólogo
Sign up to unlock all 2 contacts at Neurop, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Neurop, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.